1Hoechst AG, Abteilung für Arzneimittelsicherheit, Frankfurt/M, Germany.
Effective drug safety monitoring needs both clinical trial reporting and spontaneous reporting systems. This ensures detection and assessment of rare adverse drug reactions and their frequency for accurate risk-benefit analysis.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: